Séverine Blesson

1.0k total citations
15 papers, 397 citations indexed

About

Séverine Blesson is a scholar working on Public Health, Environmental and Occupational Health, Epidemiology and Immunology. According to data from OpenAlex, Séverine Blesson has authored 15 papers receiving a total of 397 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Public Health, Environmental and Occupational Health, 10 papers in Epidemiology and 4 papers in Immunology. Recurrent topics in Séverine Blesson's work include Research on Leishmaniasis Studies (10 papers), Trypanosoma species research and implications (10 papers) and Parasites and Host Interactions (3 papers). Séverine Blesson is often cited by papers focused on Research on Leishmaniasis Studies (10 papers), Trypanosoma species research and implications (10 papers) and Parasites and Host Interactions (3 papers). Séverine Blesson collaborates with scholars based in Switzerland, France and Ethiopia. Séverine Blesson's co-authors include Nathalie Strub‐Wourgaft, Fabiana Alves, Jorge Alvar, Olaf Valverde Mordt, Monique Wasunna, Eduard E. Zijlstra, Bernard Pécoul, Joelle Rode, Séverine Monnerat and Charles E. Mowbray and has published in prestigious journals such as Clinical Microbiology Reviews, Antimicrobial Agents and Chemotherapy and Journal of Antimicrobial Chemotherapy.

In The Last Decade

Séverine Blesson

15 papers receiving 389 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Séverine Blesson Switzerland 10 257 193 81 70 64 15 397
Grace K. Silva Brazil 9 240 0.9× 317 1.6× 66 0.8× 88 1.3× 137 2.1× 9 466
Silvia A. Longhi Argentina 14 215 0.8× 285 1.5× 49 0.6× 62 0.9× 44 0.7× 35 494
Kárita Cláudia Freitas Lidani Brazil 9 345 1.3× 463 2.4× 83 1.0× 99 1.4× 81 1.3× 29 624
Mohammad Asad India 10 176 0.7× 108 0.6× 30 0.4× 36 0.5× 53 0.8× 21 267
Juan P. Macêdo Switzerland 9 186 0.7× 142 0.7× 29 0.4× 50 0.7× 42 0.7× 12 294
Nitza A. Gomes Brazil 7 283 1.1× 193 1.0× 21 0.3× 65 0.9× 166 2.6× 7 398
G Barbieri Argentina 7 245 1.0× 330 1.7× 81 1.0× 64 0.9× 95 1.5× 14 428
Joydeep Paul India 11 149 0.6× 87 0.5× 21 0.3× 41 0.6× 104 1.6× 26 298
Ana Liempi Chile 16 133 0.5× 280 1.5× 56 0.7× 143 2.0× 75 1.2× 41 463
Thalia Pacheco‐Fernández United States 11 210 0.8× 139 0.7× 15 0.2× 54 0.8× 73 1.1× 19 326

Countries citing papers authored by Séverine Blesson

Since Specialization
Citations

This map shows the geographic impact of Séverine Blesson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Séverine Blesson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Séverine Blesson more than expected).

Fields of papers citing papers by Séverine Blesson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Séverine Blesson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Séverine Blesson. The network helps show where Séverine Blesson may publish in the future.

Co-authorship network of co-authors of Séverine Blesson

This figure shows the co-authorship network connecting the top 25 collaborators of Séverine Blesson. A scholar is included among the top collaborators of Séverine Blesson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Séverine Blesson. Séverine Blesson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Tarral, Antoine, Thierry Duvauchelle, Yves Donazzolo, et al.. (2023). Determination of the Optimal Single Dose Treatment for Acoziborole, a Novel Drug for the Treatment of Human African Trypanosomiasis: First-in-Human Study. Clinical Pharmacokinetics. 62(3). 481–491. 7 indexed citations
2.
Kuemmerle, Andrea, Caecilia Schmid, Sonja Bernhard, et al.. (2021). Effectiveness of Nifurtimox Eflornithine Combination Therapy (NECT) in T. b. gambiense second stage sleeping sickness patients in the Democratic Republic of Congo: Report from a field study. PLoS neglected tropical diseases. 15(11). e0009903–e0009903. 10 indexed citations
3.
Kip, Anke E, Séverine Blesson, Fabiana Alves, et al.. (2021). Low antileishmanial drug exposure in HIV-positive visceral leishmaniasis patients on antiretrovirals: an Ethiopian cohort study. Journal of Antimicrobial Chemotherapy. 76(5). 1258–1268. 7 indexed citations
4.
Adriaensen, Wim, Bart Cuypers, Séverine Blesson, et al.. (2020). Host transcriptomic signature as alternative test-of-cure in visceral leishmaniasis patients co-infected with HIV. EBioMedicine. 55. 102748–102748. 14 indexed citations
5.
Adriaensen, Wim, Bart Cuypers, Séverine Blesson, et al.. (2020). Host Transcriptomic Signature as Alternative Test-of-Cure in Visceral Leishmaniasis Patients Coinfected with HIV. SSRN Electronic Journal. 1 indexed citations
6.
Diro, Ermias, Tansy Edwards, Koert Ritmeijer, et al.. (2019). Long term outcomes and prognostics of visceral leishmaniasis in HIV infected patients with use of pentamidine as secondary prophylaxis based on CD4 level: a prospective cohort study in Ethiopia. PLoS neglected tropical diseases. 13(2). e0007132–e0007132. 22 indexed citations
7.
Alves, Fabiana, Graeme Bilbe, Séverine Blesson, et al.. (2018). Recent Development of Visceral Leishmaniasis Treatments: Successes, Pitfalls, and Perspectives. Clinical Microbiology Reviews. 31(4). 142 indexed citations
8.
Kip, Anke E, Hilde Rosing, M. J. X. Hillebrand, et al.. (2016). Validation and Clinical Evaluation of a Novel Method To Measure Miltefosine in Leishmaniasis Patients Using Dried Blood Spot Sample Collection. Antimicrobial Agents and Chemotherapy. 60(4). 2081–2089. 16 indexed citations
9.
Mordt, Olaf Valverde, et al.. (2016). A DBS Method for Quantitation of The New Oral Trypanocidal Drug Fexinidazole and its Active Metabolites. Bioanalysis. 8(19). 2045–2063. 4 indexed citations
10.
Tarral, Antoine, Séverine Blesson, Olaf Valverde Mordt, et al.. (2014). Determination of an Optimal Dosing Regimen for Fexinidazole, a Novel Oral Drug for the Treatment of Human African Trypanosomiasis: First-in-Human Studies. Clinical Pharmacokinetics. 53(6). 565–580. 69 indexed citations
11.
Schmid, Caecilia, Andrea Kuemmerle, Johannes Blum, et al.. (2012). In-Hospital Safety in Field Conditions of Nifurtimox Eflornithine Combination Therapy (NECT) for T. b. gambiense Sleeping Sickness. PLoS neglected tropical diseases. 6(11). e1920–e1920. 28 indexed citations
12.
Bielawska‐Pohl, Aleksandra, Séverine Blesson, Houssem Benlalam, et al.. (2010). The anti-angiogenic activity of IL-12 is increased in iNOS−/− mice and involves NK cells. Journal of Molecular Medicine. 88(8). 775–784. 17 indexed citations
13.
Blesson, Séverine, Jérôme Thiery, Catherine Gaudin, et al.. (2002). Analysis of the mechanisms of human cytotoxic T lymphocyte response inhibition by NO. International Immunology. 14(10). 1169–1178. 30 indexed citations
14.
Asselin‐Paturel, Carine, Isabelle Vergnon, Hamid Echchakir, et al.. (2001). Differential effect of high doses versus low doses of interleukin-12 on the adoptive transfer of human specific cytotoxic T lymphocyte in autologous lung tumors engrafted into severe combined immunodeficiency disease-nonobese diabetic mice: relation with interleukin-10 induction.. PubMed. 91(1). 113–22. 27 indexed citations
15.
Blesson, Séverine, et al.. (1994). [Hemolytic anemia after kidney transplantation].. PubMed. 23(15). 707–9. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026